Trials / Conditions / Anaplastic Large Cell Lymphoma, ALK-negative

Anaplastic Large Cell Lymphoma, ALK-negative

12 registered clinical trials studyying Anaplastic Large Cell Lymphoma, ALK-negative — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Constitutive IL7R (C7R) Modified Banked Allogeneic CD30.CAR EBVSTS for CD30-Positive Lymphomas NCT06176690	Baylor College of Medicine	Phase 1
Not Yet Recruiting	Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patie NCT06724237	Eastern Cooperative Oncology Group	Phase 3
Recruiting	A Registry for People With T-cell Lymphoma NCT05978141	Memorial Sloan Kettering Cancer Center	—
Unknown	CD7-CART in the Treatment of r / r CD7 Positive Hemolymph System Malignancies on Increasing Dose and Open Labe NCT04480788	PersonGen BioTherapeutics (Suzhou) Co., Ltd.	Phase 1
Completed	Study of BGB-A317 in Participants With Relapsed or Refractory Mature T- and NK-cell Neoplasms NCT03493451	BeiGene	Phase 2
Active Not Recruiting	Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractor NCT02978625	National Cancer Institute (NCI)	Phase 2
Active Not Recruiting	Brentuximab Vedotin and Combination Chemotherapy in Treating Patients With CD30-Positive Peripheral T-cell Lym NCT03113500	City of Hope Medical Center	Phase 2
Completed	Risk Stratification of Nodal PTCL NCT03040206	Chonbuk National University Hospital	—
Completed	Combination Chemotherapy & Lenalidomide in Newly Diagnosed Stage II-IV Peripheral T-cell Non-Hodgkin's Lymphom NCT02561273	University of Nebraska	Phase 1 / Phase 2
Unknown	CHOP vs GEM-P in 1st Line Treatment of T-cell Lymphoma, Multicentre Phase II Study NCT01719835	Royal Marsden NHS Foundation Trust	Phase 2
Completed	RAD001 Combined With CHOP in Newly Diagnosed Peripheral T-cell Lymphomas NCT01198665	Samsung Medical Center	Phase 1 / Phase 2
Completed	Lenalidomide Therapy After Chemotherapy & Stem Cell Transplant in Treating Chemotherapy Resistan Non-Hodgkin L NCT01035463	University of Nebraska	Phase 1 / Phase 2